Company Filings Shed Light on Trump’s Drug Pricing Deals
3 Articles
3 Articles
Company Filings Shed Light on Trump’s Drug Pricing Deals
Sixteen drugmakers have entered into or are negotiating confidential pricing deals with the Trump administration. Apart from the broad strokes laid out in public announcements, most details remain unknown. President Donald Trump’s aim in making the deals is to correct the longstanding practice by pharmaceutical companies of charging Americans about three times more for prescription medications than those in other countries. The president announc…
Americans pay some of the highest prices for medicines in the world. This article will explain how the Trump Prescription Drug Program (TrumpRx) can reduce costs for uninsured patients.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



